Pharmaceuticals
-
Scepticism about Covid-19 vaccine speed
Analysts have warned that a vaccine for the Covid-19 virus could be a year away, in spite of the first vaccine going for phase 1 testing. Read more
-
New migraine treatment gains backing
Up to 10,000 people in England could be offered a new anti-migraine self-injected drug, it was announced today. Read more
-
Chemotherapy after surgery halves risk of kidney cancer relapse
Chemotherapy halves the risk of a rare form of kidney cancer returning following surgery, according to the findings of a major trial reported today. Read more
-
Child vaccine clue to cancer therapy
The “immunological memory” of common childhood vaccines could provide a basis for new cancer treatments, according to a research team in Finland. Read more
-
Anti-scar drug could boost cancer therapy
A drug developed to treat scarring could play a key role in improving the effectiveness of immunotherapy against solid tumours, British researchers reported last night. Read more
-
Antibiotics linked to hospital admissions
High levels of antibiotic prescription are linked to increased risk of hospital admission, according to a UK analysis published today. Read more
-
Benefit of immune therapy for high-risk breast cancer
Immune therapy can substantially reduce the risk of relapse for the most aggressive form of breast cancer, researchers reported last night. Read more
-
Project for brain tumour test begins
Fluorescent carbon dots and nanophotonics are being used in a new project aiming to improve diagnosis of brain tumours. Read more
-
Electronic nose detects Barrett’s
An electronic nose can accurately detect Barrett’s oesophagus, providing a potential new portable diagnostic test, Dutch researchers report today. Read more
-
Antibiotic risk in pregnancy
Taking macrolide antibiotics in pregnancy may be linked to subsequent birth defects, researchers warned today. Read more
